The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
Experts hope to create a blood test to see which patients with inflammatory bowel disease are most at risk of bowel cancer.
Baseline histologic activity predicted colectomy risk in ulcerative colitis treated with biologics, independent of clinical or endoscopic factors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback